Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation
Activation of inflammatory pathways via reactive oxygen species (ROS) by free fatty acids (FFA) in obesity gives rise to insulin resistance and endothelial dysfunction. Withaferin A (WA), possesses both antioxidant and anti-inflammatory properties and therefore would be a good strategy to suppress p...
Main Authors: | Batumalaie, K., Amin, M.A., Murugan, D.D., Sattar, M.Z.A., Abdullah, N.A. |
---|---|
Format: | Article |
Published: |
Nature Publishing Group
2016
|
Subjects: |
Similar Items
-
Celastrol attenuates mitochondrial dysfunction and inflammation in palmitate-mediated insulin resistance in C3A hepatocytes
by: Abu Bakar, M. H., et al.
Published: (2017) -
Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice.
by: Manizheh Khalilpourfarshbafi, et al.
Published: (2019-01-01) -
Inhibition of Monosodium Urate Crystal-Induced Inflammation by Withaferin A
by: Mahaboobkhan Rasool, et al.
Published: (2009-01-01) -
Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions
by: Sneham Tiwari, et al.
Published: (2018-09-01) -
Tackling Chronic Inflammation with Withanolide Phytochemicals—A Withaferin A Perspective
by: Emilie Logie, et al.
Published: (2020-11-01)